WVU020925: A Multicenter Phase II Study of Subcutaneous Blinatumomab for Treatment of Adult Patients with CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)
- Title
- A Multicenter Phase II Study of Subcutaneous Blinatumomab for Treatment of Adult Patients with CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)
- Principal Investigator
- Emadi, Ashkan
- Phase
- II
- Age Group
- Adult
- Applicable Disease Sites
- Leukemia
- Multiple Myeloma
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Abby Swiger, RN
- Research Nurse
- Phone: +1 304-293-1683
- Email: aswiger3@hsc.wvu.edu